Abstract
- The Silvant Giant Cap Progress SMA returned +18.62% (gross)/+17.74% (internet) for the quarter, outperforming the Russell 1000 Progress Index’s return of +17.84%.
- NVIDIA and Apple have been among the many prime inventory contributors to relative efficiency. UnitedHealth and Eli Lilly have been among the many largest inventory detractors from relative efficiency.
- New positions included Boston Scientific and Cloudflare. Along with UnitedHealth, exits included Colgate-Palmolive.
Shutthiphong Chandaeng/iStock through Getty Pictures
Portfolio Overview
The Silvant Giant Cap Progress SMA (MUTF:STCAX) returned +18.62% (gross)/+17.74% (internet) for the quarter, outperforming the Russell 1000 Progress Index’s return of +17.84%. Inventory choice in client discretionary and industrials and an underweight and inventory choice in client
Choose quarterly mutual fund commentaries.













